BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25511707)

  • 1. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
    Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE; Ward K; Rickinson AB; Rowe M
    Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
    Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide inhibits transcription of hTERT through down-regulation of transcription factor specificity protein 1 in primary effusion lymphoma cells.
    Long C; Wang J; Guo W; Wang H; Wang C; Liu Y; Sun X
    Biochem Biophys Res Commun; 2016 Jan; 469(1):87-93. PubMed ID: 26631963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
    Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV latent membrane protein 1 is a negative regulator of TLR9.
    Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
    J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
    Huang H; Huang PC
    Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model for acute Epstein-Barr virus infection.
    Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
    Diamantopoulos PT; Polonyfi K; Sofotasiou M; Mantzourani M; Galanopoulos A; Spanakis N; Papadopoulou V; Kalala F; Iliakis T; Zareifi DS; Kodandreopoulou E; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Terpos E; Variami E; Kollia P; Vaiopoulos G; Pangalis G; Viniou NA
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):56-60. PubMed ID: 24262330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.